We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Apellis Hopes for Another Empaveli Win, This Time for an Eye Disease
Apellis Hopes for Another Empaveli Win, This Time for an Eye Disease
Apellis Pharmaceuticals said it will proceed with a new drug application (NDA) for an injectable form of Empaveli (pegcetacoplan) for treatment of geographic atrophy (GA), the leading cause of blindness in the elderly, despite conflicting results from two late-stage studies.